Secondary analysis of 287 patients with high-risk soft-tissue sarcoma (ISG-STS 1001 trial): preoperative chemotherapy with concurrent radiotherapy vs chemotherapy alone was linked to similar blood toxicity, more seroma (10.4% vs 2.8%) and more RECIST responses (20.3% vs 9.8%).
Secondary analysisn = 287
Palassini et al. Feasibility and Activity of Concurrent Neoadjuvant Chemotherapy and Radiotherapy in Patients with High-risk Soft-Tissue Sarcoma